Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization

N Sheibani, S Wang, SR Darjatmoko, DL Fisk… - Experimental eye …, 2019 - Elsevier
Abnormal migration and proliferation of endothelial cells (EC) drive neovascular
retinopathies. While anti-VEGF treatment slows progression, pathology is often supported by …
被引用次数：25 相关文章

Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization

N Sheibani, S Wang, SR Darjatmoko… - Experimental Eye …, 2019 - ohsu.elsevierpure.com
Abnormal migration and proliferation of endothelial cells (EC) drive neovascular
retinopathies. While anti-VEGF treatment slows progression, pathology is often supported by …

Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization

N Sheibani, S Wang… - Experimental …, 2019 - mdanderson.elsevierpure.com
Abnormal migration and proliferation of endothelial cells (EC) drive neovascular
retinopathies. While anti-VEGF treatment slows progression, pathology is often supported by …

Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization.

N Sheibani, S Wang, SR Darjatmoko… - Experimental eye …, 2019 - europepmc.org
Abnormal migration and proliferation of endothelial cells (EC) drive neovascular
retinopathies. While anti-VEGF treatment slows progression, pathology is often supported by …

[引用][C] Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization

N Sheibani, S Wang, SR Darjatmoko, DL Fisk… - Experimental Eye …, 2019 - cir.nii.ac.jp
Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[PDF] academia.edu

[PDF][PDF] Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization

N Sheibani, S Wang, SR Darjatmoko… - Experimental Eye …, 2019 - academia.edu
Abnormal migration and proliferation of endothelial cells (EC) drive neovascular
retinopathies. While anti-VEGF treatment slows progression, pathology is often supported by …

Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization

N Sheibani, S Wang, SR Darjatmoko… - Experimental eye …, 2019 - scholars.northwestern.edu
Abnormal migration and proliferation of endothelial cells (EC) drive neovascular
retinopathies. While anti-VEGF treatment slows progression, pathology is often supported by …

Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization

N Sheibani, S Wang, SR Darjatmoko… - Experimental eye …, 2019 - pubmed.ncbi.nlm.nih.gov
Abnormal migration and proliferation of endothelial cells (EC) drive neovascular
retinopathies. While anti-VEGF treatment slows progression, pathology is often supported by …
[HTML] nih.gov

[HTML][HTML] Novel Anti-Angiogenic PEDF-Derived Small Peptides Mitigate Choroidal Neovascularization

N Sheibani, S Wang, SR Darjatmoko… - Experimental eye …, 2019 - ncbi.nlm.nih.gov
Abnormal migration and proliferation of endothelial cells (EC) drive neovascular
retinopathies. While anti-VEGF treatment slows progression, pathology is often supported by …
[PDF] academia.edu

[PDF][PDF] Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization

N Sheibani, S Wang, SR Darjatmoko… - Experimental Eye …, 2019 - academia.edu
Abnormal migration and proliferation of endothelial cells (EC) drive neovascular
retinopathies. While anti-VEGF treatment slows progression, pathology is often supported by …